Michelle Kirschner, MSN, RN, ACNP, APRN-BC, discusses how precision supportive care tailors interventions to patient needs.

The NDA’s acceptance is based on positive data from the phase 3 ROSELLA trial (NCT05257408) as well as from a previous phase ...

Tepotinib was associated with frequent but manageable adverse events in MET exon 14–positive NSCLC, with peripheral edema ...

Formerly known as TAR-200, gemcitabine intravesical system has received the FDA’s approval for use in patients with ...

Other AEs linked to menin inhibitors include cytopenias and mild gastrointestinal symptoms, such as nausea. Still, Issa noted ...

Expert Kelsey Martin shares nursing insights on balancing glucose control and GI side effects when caring for patients on ...

New AQUILA data show PFS improvement in patients with smoldering multiple myeloma who were treated with subcutaneous ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient ...

Glucagon-like peptide-1 receptor agonists (GLP-1a) were associated with reduced all-cause mortality, progression to myelofibrosis, venous thromboembolism (VTE), hospitalization, intensive care unit ...

Familiarity with each component of antibody-drug conjugates helps nurses and APPs deliver proactive adverse event management ...